相关实验视频
Updated: Jul 3, 2026
08:43
Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
炎症性肠病中的实验室测试:一种基于证据的日常实践方法
Katelin Durham1,2, Tyler Atagozli3, David E Elliott1,2
1Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, USA.
Biomedicines
|February 26, 2025
概括
实验室测试对于管理炎症性肠病 (IBD),帮助诊断,监测治疗反应和预防生物药物等药物并发症至关重要.
科学领域:
- 胃肠病学 胃肠病学
- 临床免疫学临床免疫学
- 内部医学 内部医学
背景情况:
- 炎症性肠病 (IBD) 是一种慢性胃肠道疾病,具有复发缓解的过程.
- 目前的IBD治疗依赖于包括类固醇,免疫调节剂,生物制剂和小分子在内的药物,这些药物具有严重毒性风险.
- 实验室检测对于IBD诊断,疾病活性评估,监测治疗疗效和毒性以及检测感染和营养不足等并发症至关重要.
研究的目的:
- 探索IBD管理中使用的各种实验室测试.
- 总结这些测试在日常实践中的临床应用.
- 要突出治疗药物监测 (TDM) 对IBD生物疗法的更新.
主要方法:
- 审查IBD的既定和新兴实验室测试.
- 分析实验室测试在诊断,疾病监测和毒性监测中的作用.
- 专注于治疗药物监测 (TDM) 在生物疗法的背景下不断变化的实用性.
主要成果:
- 实验室测试有助于评估疾病活性,监测药物反应和毒性,并查感染 (如结核病,乙型肝炎) 和缺乏 (如维生素B12).
- 既定的实验室实践被新的测试所补充,例如生物制剂的TDM,这是正在进行的研究和临床演变的领域.
- 虽然实验室测试不能取代临床评估,成像,内镜或组织学,但在综合性IBD护理中,实验室测试是有价值的补充.
结论:
- 实验室测试是IBD综合管理中不可或缺的工具,支持患者护理各方面的临床决策.
- 常规实验室监测对于优化治疗效益,同时减轻与免疫抑制疗法相关的风险至关重要.
- 综合先进的实验室诊断,包括TDM,代表了个性化IBD治疗策略的重大发展.
相关概念视频
01:17Chronic Bowel Disorders: Introduction
378
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
378
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
112
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
112
01:30Inflammatory Bowel Disease II: Crohn's Disease
157
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
157
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
294
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
294
01:29Inflammatory Bowel Disease IV: Pharmacological Management
89
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
89
01:30Serum Laboratory Studies, Stool Test, Breath Test
297
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
297